Topic

Washington

A collection of 516 issues

Myths vs. Facts: Getting Koselugo (Selumetinib) Covered by Blue Cross Blue Shield in Washington - Appeals Guide 2025

Answer Box: Getting Koselugo Covered by Blue Cross Blue Shield in Washington Fastest path to approval: Submit a complete prior authorization with confirmed NF1 diagnosis, imaging showing symptomatic plexiform neurofibromas, baseline cardiac/eye evaluations, and proof the tumors are inoperable. Most BCBS plans require these specific documents upfront. If denied,

Get Pemazyre (Pemigatinib) Covered by Blue Cross Blue Shield in Washington: Prior Authorization Forms, Appeal Deadlines & Success Strategies

Answer Box: Getting Pemazyre Covered in Washington Pemazyre (pemigatinib) requires prior authorization from Blue Cross Blue Shield plans in Washington. Success depends on documenting FGFR2 fusion/rearrangement, prior therapy failure, and an ophthalmic monitoring plan. If denied, Washington's external review process through an Independent Review Organization (IRO) provides

How to Get Tavalisse (Fostamatinib) Covered by Cigna in Washington: Complete Prior Authorization & Appeal Guide

Quick Answer: Getting Tavalisse Covered by Cigna in Washington Fastest path to approval: Your hematologist must submit a prior authorization showing you've tried and failed corticosteroids and at least one other ITP therapy (like IVIG or a TPO receptor agonist), with documented platelet counts <30,000/µL.

How to Get HyperHEP B (Hepatitis B Immune Globulin) Covered by Humana in Washington: Prior Authorization Forms, Appeals, and State Resources

Answer Box: Getting HyperHEP B Covered by Humana in Washington HyperHEP B (hepatitis B immune globulin) requires prior authorization from Humana in Washington state. Submit your PA request through Humana's Prior Authorization Search Tool with exposure documentation, vaccination history, and CDC guideline justification. For post-exposure prophylaxis, timing is

How to Get Eylea and Lucentis Covered by Aetna CVS Health in Washington: Complete Appeals Guide

Answer Box: Getting Eylea/Lucentis Covered by Aetna in Washington Aetna CVS Health requires prior authorization for both Eylea and Lucentis in Washington. Lucentis is non-preferred with biosimilar alternatives (Byooviz, Cimerli) required first. If denied, you have 21 days to file for external review through Washington's Office of

How to Get Vanflyta (Quizartinib) Covered by UnitedHealthcare in Washington: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Vanflyta Covered by UnitedHealthcare in Washington Vanflyta (quizartinib) requires prior authorization from UnitedHealthcare for FLT3-ITD positive AML. Submit documentation of FLT3-ITD mutation testing, EKG showing QTc ≤450ms, and medical necessity justification through the UnitedHealthcare Provider Portal. If denied, Washington residents have strong appeal rights including external review

How to Get Tysabri (natalizumab) Covered by Aetna (CVS Health) in Washington: Complete Prior Authorization Guide

Quick Answer: Getting Tysabri Covered by Aetna in Washington Tysabri (natalizumab) requires prior authorization from Aetna CVS Health for all plans. You'll need a neurologist (for MS) or gastroenterologist (for Crohn's) to submit clinical documentation proving diagnosis, prior biologic failures, and TOUCH program enrollment. First step

How to Get Imbruvica (Ibrutinib) Covered by UnitedHealthcare in Washington: Prior Authorization, Appeals, and Templates

Answer Box: Getting Imbruvica Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Imbruvica (ibrutinib) but doesn't mandate step therapy for CLL, SLL, or Waldenström macroglobulinemia. The fastest path: (1) Submit complete PA with pathology, diagnosis, and treatment history; (2) If denied, file internal appeal within 180

How to Get Tagrisso (Osimertinib) Covered by UnitedHealthcare in Washington: Prior Authorization Guide & Appeal Steps

Answer Box: Getting Tagrisso Covered by UnitedHealthcare in Washington You can get Tagrisso (osimertinib) covered by UnitedHealthcare in Washington if you have EGFR-mutated non-small cell lung cancer (NSCLC) and meet prior authorization criteria. The fastest path: ensure your oncologist has documented EGFR mutation test results (exon 19 deletion or L858R)

How to Get Filspari (Sparsentan) Covered by Blue Cross Blue Shield in Washington: 2025 Forms, Appeals & Contacts

Answer Box: Getting Filspari Covered in Washington Filspari (sparsentan) requires prior authorization and REMS program enrollment for Blue Cross Blue Shield coverage in Washington. Your fastest path: (1) Enroll prescriber and patient in the Filspari REMS program, (2) Submit the PA form via your plan's provider portal (Availity